TCS 359 - Moligand™, ≥99% , Inhibitor of fms related receptor tyrosine kinase 3, CAS No.301305-73-7, Inhibitor of fms related receptor tyrosine kinase 3

CAS: 301305-73-7 Cat. No.: T129806 Fórmula: C18H20N2O4S Peso molecular: 360.43 Número EC: 636-890-8 PubChem CID: 1048845
Disponible para pedir
CALIDAD & PUREZA Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥99%
Synonyms
2-[(3,4-dimethoxybenzoyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide|Flt-3 Inhibitor - CAS 301305-73-7|FLT3 Inhibitor|Flt-3 inhibitor|2-(3,4-dimethoxybenzamido)-5-methyl-4-propylthiophene-3-carboxamide|2-[(3,4-Dimethoxybenzoyl)amino]-4,5,6,7-benzo[b]thiophene-3-carboxamide|TCS359|TCS-359|2-(3,4-Dimethoxy-benzoylamino)-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid amide|2-{[(3,4-dimethoxyphenyl)carbonyl]amino}-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide|2-(3,4-dimethoxybenzamido)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide|FLT-3|2-[(3,4-dimethoxybenzene)amido]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide|2-(3,4-Dimethoxyphenylcarbamoyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide|Benzo[b]thiophene-3-carboxamide,2-[(3,4-dimethoxybenzoyl)amino]-4,5,6,7-tetrahydro-|2-(3,4-dimethoxybenzamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxamide|TCS 359
Storage
Store at -20°C,Argon charged
Shipped In
Ice chest + Ice pads
★
Talla
Alemania (EU)
USA*
Precio
Cantidad
10mg
T129806-10mg
—
3 Disponible

36,36€

54,58€
Guardar 18,22 € (33.39%)
25mg
T129806-25mg
—
1 Disponible

79,75€

119,66€
Guardar 39,92 € (33.36%)
50mg
T129806-50mg
—
2 Disponible

98,84€

148,30€
Guardar 49,46 € (33.35%)
100mg
T129806-100mg
Fabricado bajo pedido · 8–12 semanas

161,31€

242,01€
Guardar 80,70 € (33.35%)
Enter a quantity for the sizes you want to add.

Descripción general

TCS 359, a 2-acylaminothiophene-3-carboxamide, is a potent and selective FLT3 inhibitor with an IC50 of 42 nM. TCS 359 inhibits MV4-11 cell proliferation with an IC50 of 340 nM.

A cell-permeable thienylcarboxamide compound that acts as a potent, ATP-competitive, and highly selective Flt-3 inhibitor

Especificaciones

Sinónimos
2-[(3,4-dimethoxybenzoyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide | Flt-3 Inhibitor - CAS 301305-73-7 | FLT3 Inhibitor | Flt-3 inhibitor | 2-(3,4-dimethoxybenzamido)-5-methyl-4-propylthiophene-3-carboxamide | 2-[(3,4-Dimethoxybenzoyl)amino]-4,5,6,7-benzo[b]thiophene-3-carboxamide | TCS359 | TCS-359 | 2-(3,4-Dimethoxy-benzo Show more
Especificaciones y pureza
Moligand™, ≥99%
Mecanismos bioquímicos y fisiológicos
Description:IC50 Value: 42 nM [1]TCS 359, a 2-acylaminothiophene-3-carboxamide, is a potent inhibitor of FLT3 with IC50 of 42 nM.in vitro: TCS 359, a 2-acylaminothiophene-3-carboxamide, is a potent inhibitor of FLT3 with IC50 of 42 nM. TCS 359 inhibits MV4-11 proliferation with IC50 of 340 nM. TCS 359 is highly selective for FLT3 against a panel of kinases [1].in vivo: N/AToxicity: N/AClinical trial: N/A .Potent FLT3 receptor tyrosine kinase inhibitor (IC 50 = 42 nM). Selective over 22 other kinases. Shows antiproliferative effects (IC 50 = 340 nM for Human acute myelocytic leukemia MV4-11 cells).
Condiciones de almacenamiento de almacenamiento
Store at -20°C,Argon charged
Enviado en
Ice chest + Ice pads
Este producto requiere envío en cadena de frío. Los servicios terrestres y otros servicios económicos no están disponibles.
Grado
Moligand™
Tipo de acción
INHIBITOR
Mecanismo de acción
Inhibitor of fms related receptor tyrosine kinase 3
Nota
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Pureza
≥99%
Nombres e identificadores
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/504760370
SMILES
COC1=C(C=C(C=C1)C(=O)NC2=C(C3=C(S2)CCCC3)C(=O)N)OC
IUPAC Name
2-[(3,4-dimethoxybenzoyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide
InChIKey
FSPQCTGGIANIJZ-UHFFFAOYSA-N
InChI
1S/C18H20N2O4S/c1-23-12-8-7-10(9-13(12)24-2)17(22)20-18-15(16(19)21)11-5-3-4-6-14(11)25-18/h7-9H,3-6H2,1-2H3,(H2,19,21)(H,20,22)
Isómeros SMILES
COC1=C(C=C(C=C1)C(=O)NC2=C(C3=C(S2)CCCC3)C(=O)N)OC
WGK Alemania
3
PubChem CID
1048845
Peso molecular
360.43

Datos avanzados

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassBenzenoids
ClaseBenzene and substituted derivatives
SubclassMethoxybenzenes
Intermediate Tree Nodes Not available
Direct ParentDimethoxybenzenes
Alternative Parents Benzamides  Thiophene carboxamides  Phenoxy compounds  Benzoyl derivatives  Anisoles  Alkyl aryl ethers  Vinylogous amides  Heteroaromatic compounds  Secondary carboxylic acid amides  Primary carboxylic acid amides  Organopnictogen compounds  Organonitrogen compounds  Organic oxides  Hydrocarbon derivatives  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents O-dimethoxybenzene - Dimethoxybenzene - Benzamide - Benzoic acid or derivatives - Phenoxy compound - Anisole - Benzoyl - Phenol ether - Thiophene carboxamide - Thiophene carboxylic acid or derivatives - Alkyl aryl ether - Heteroaromatic compound - Vinylogous amide - Thiophene - Secondary carboxylic acid amide - Primary carboxylic acid amide - Carboxamide group - Ether - Carboxylic acid derivative - Organoheterocyclic compound - Organic nitrogen compound - Organooxygen compound - Organonitrogen compound - Hydrocarbon derivative - Organic oxide - Organopnictogen compound - Organic oxygen compound - Aromatic heteropolycyclic compound
DescripciónThis compound belongs to the class of organic compounds known as dimethoxybenzenes. These are organic aromatic compounds containing a monocyclic benzene moiety carrying exactly two methoxy groups.
External Descriptors Not available
Estructura 3D
Modelo de Estructura Química Interactiva





Objetivos asociados (humanos)
FLT3 Tclin Receptor-type tyrosine-protein kinase FLT3 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ABL1 Tclin Tyrosine-protein kinase ABL (18331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
INSR Tclin Insulin receptor (5558 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDGFRB Tclin Platelet-derived growth factor receptor beta (5195 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IGF1R Tclin Insulin-like growth factor I receptor (8605 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KIT Tclin Stem cell growth factor receptor (10667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DAPK3 Tchem Death-associated protein kinase 3 (2108 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK11 Tchem MAP kinase p38 beta (2785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LCK Tclin Tyrosine-protein kinase LCK (9212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3B Tclin Glycogen synthase kinase-3 beta (11785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKCZ Tchem Protein kinase C zeta (2414 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP2K6 Tchem Dual specificity mitogen-activated protein kinase kinase 6 (1284 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MYLK Tchem Myosin light chain kinase, smooth muscle (1267 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK1G1 Tchem Casein kinase I gamma 1 (2496 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR2 Tclin Fibroblast growth factor receptor 2 (3405 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR1 Tclin Fibroblast growth factor receptor 1 (9149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
STK3 Tchem Serine/threonine-protein kinase MST2 (3069 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK1D Tchem Casein kinase I delta (4546 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAMK2B Tchem CaM kinase II beta (1626 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SRC Tclin Tyrosine-protein kinase SRC (10310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHEK2 Tchem Serine/threonine-protein kinase Chk2 (4015 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDPK1 Tchem 3-phosphoinositide dependent protein kinase-1 (3758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT2 Tchem Serine/threonine-protein kinase AKT2 (4301 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT3 Tchem Serine/threonine-protein kinase AKT3 (3157 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHUK Tchem Inhibitor of nuclear factor kappa B kinase alpha subunit (3170 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IKBKB Tchem Inhibitor of nuclear factor kappa B kinase beta subunit (5554 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DAPK2 Tchem Death-associated protein kinase 2 (740 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AURKB Tchem Serine/threonine-protein kinase Aurora-B (6805 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPS6KA4 Tchem Ribosomal protein S6 kinase alpha 4 (2104 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ROCK1 Tclin Rho-associated protein kinase 1 (4723 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIM1 Tchem Serine/threonine-protein kinase PIM1 (9629 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PKN2 Tchem Protein kinase N2 (1991 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSK Tchem Tyrosine-protein kinase CSK (2395 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK3 Tclin Tyrosine-protein kinase JAK3 (8349 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPS6KA5 Tchem Ribosomal protein S6 kinase alpha 5 (3355 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKCE Tchem Protein kinase C epsilon (1520 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKCG Tchem Protein kinase C gamma (2471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKCI Tchem Protein kinase C iota (2821 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKD1 Tchem Protein kinase C mu (1904 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAF1 Tclin Serine/threonine-protein kinase RAF (4169 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SYK Tclin Tyrosine-protein kinase SYK (7372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLK1 Tchem Serine/threonine-protein kinase PLK1 (28605 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITK Tclin Tyrosine-protein kinase ITK/TSK (3699 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPS6KA1 Tchem Ribosomal protein S6 kinase alpha 1 (2796 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK2 Tclin Tyrosine-protein kinase JAK2 (12915 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPS6KA6 Tchem Ribosomal protein S6 kinase alpha 6 (2027 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAMK1 Tchem CaM kinase I alpha (1664 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAMK4 Tbio CaM kinase IV (2116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT1 Tclin Vascular endothelial growth factor receptor 1 (6262 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Objetivos asociados (no humanos)
Prkcd Protein kinase C delta (192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Prkcb Protein kinase C beta (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk1 MAP kinase ERK2 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fgfr4 Fibroblast growth factor receptor 4 (138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fgfr3 Fibroblast growth factor receptor 3 (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Camk2g CaM kinase II gamma (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Tec Tyrosine-protein kinase TEC (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FTL Ferritin light chain (43324 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mecanismos de acción
Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot NumberCertificate TypeFechaArticulo
D2102250D2102250Certificate of AnalysisJul 03, 2026 T129806
D2102251D2102251Certificate of AnalysisJul 03, 2026 T129806
D2102253D2102253Certificate of AnalysisJul 03, 2026 T129806
Propiedades químicas y físicas
SolubilidadDMSO 15 mg/mL Water <1 mg/mL Ethanol <1 mg/mL
SensibilidadLight sensitive
Peso molecular360.400 g/mol
XLogP33.400
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count5
Exact Mass360.114 Da
Monoisotopic Mass360.114 Da
Topological Polar Surface Area119.000 Ų
Heavy Atom Count25
Formal Charge0
Complexity503.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Preguntas frecuentes y artículos
Calculadoras de soluciones
Reseñas

Reseñas de cliente

Application Protocols

Validated application types, recommended dilutions, and positive controls for this specific product are not included in the provided data.

General protocol framework (research use)

  • Cell culture dosing: Prepare a 10–50 mM DMSO stock; add to culture medium to desired concentration ensuring constant vehicle percentage. Include vehicle-only controls and, where available, a reference compound.
  • Dose–response: Serially dilute 1:3 or 1:2 in assay medium to cover several orders of magnitude. Incubation times commonly range from 0.5 to 48 h depending on readout.
  • Readouts: Choose orthogonal endpoints (e.g., viability assays, phospho-protein immunoblots, reporter assays) and confirm reproducibility across replicates.
  • In vitro biochemical assays: Maintain substrate and cofactor concentrations within Km-like ranges; titrate compound to define IC50/EC50 curves.

For item-specific, validated conditions, please consult the CoA/Spec Sheet or contact technical support with your application details.

Biological Roles

This item is a research-grade small-molecule ligand (Moligand™) intended for pathway modulation and target interrogation in life-science studies.

General notes (literature)

  • Small-molecule ligands are frequently used as reversible, titratable modulators of enzyme or receptor function, enabling temporal control compared with genetic methods. They facilitate studies on signaling cascades, feedback loops, and phenotypic consequences in cells and model organisms.
  • Typical readouts include phosphorylation changes, reporter gene activation, transcriptional profiling, and morphological/functional phenotypes. Robust interpretation usually combines chemical probing with orthogonal genetic validation to strengthen causality.
  • Dose selection: Start with broad ranges (e.g., 0.01–30 µM) and refine based on potency reported in literature for analogous scaffolds, while ensuring solvent controls remain constant.

Item-specific target information

  • Target specificity, binding constants, and selectivity panels are not provided in the product data. Consult primary literature associated with the CAS (301305-73-7) and PubChem CID (1048845), and verify with the lot-specific CoA.

Assay implementation

  • Prepare DMSO stocks (e.g., 10–50 mM) and dilute into pre-warmed media immediately before dosing to limit precipitation.
  • Consider protein binding in serum-containing media; apparent potency may shift relative to cell-free assays.

All applications are for research use only. No medical or clinical uses are implied.

Buffer Applications

TCS 359 is not a buffering agent. However, buffers are central to its biological use as a dissolved ligand.

Practical guidance (general)

  • Vehicle: Prepare concentrated DMSO stocks and dilute into biological buffers (e.g., PBS, HEPES, Tris-buffered saline) or culture media immediately before use. Maintain constant vehicle percentage across all conditions.
  • pH considerations: Many small molecules exhibit pH-dependent solubility and stability. Maintain assay buffers within physiological pH (7.2–7.6) unless a specific protocol dictates otherwise.
  • Precipitation control: Add compound stocks to vigorously agitated buffer, or pre-mix with a small volume of buffer containing surfactant-free BSA (0.1–0.5%) when compatible, to reduce nonspecific adsorption and nucleation.
  • Storage in buffer: Avoid long-term storage of working dilutions in aqueous buffer; prepare fresh prior to dosing to mitigate hydrolysis or oxidation.

Item-specific buffer properties (pKa, buffer range, ionic effects): Not applicable/not specified for this item.

Green Alternatives

Greener practices for small-molecule ligand handling focus on solvent choice and waste minimization rather than substituting the active compound itself.

Strategies (general, literature)

  • Prefer aqueous buffers with minimal DMSO: Maintain solubility while keeping final DMSO ≤0.1–0.5% v/v when biological tolerance permits.
  • Consider ethanol or glycerol/PEG400 co-solvent systems when compatible with the assay, to reduce DMSO usage. Validate no assay interference.
  • Implement microscale dosing (acoustic or pin-tool transfers) to lower solvent and compound consumption.
  • Consolidate aliquot sizes to experimental needs to minimize freeze–thaw cycles and waste.

Comparison of common vehicles (literature)

  • DMSO: High solvency; not green; excellent chemical stability; biological effects above ~0.5–1%.
  • Ethanol: Renewable routes available; more benign; volatile for easy removal; reduced solvency for some chemotypes.
  • PEG400: Less volatile; lower toxicity; increases viscosity and may affect diffusion/assays.

Operational green tips

  • Use closed, inert-gas-charged vials for long storage to prevent degradation and repeat syntheses.
  • Plan serial dilutions to produce only the volumes required for each run, reducing waste.

Note: No greener “substitute compound” is proposed because target engagement is structure-specific; maintaining probe identity is essential for reproducible biology.

Pharmaceutical Uses

This product is supplied strictly for research use only.

  • No pharmacopeial or excipient status is claimed or implied.
  • Not manufactured to GMP for human administration, clinical use, or veterinary use.

Formulation context (research only)

  • In preclinical research, small-molecule ligands may be formulated for in vivo studies using common vehicles (e.g., DMSO/PEG400/saline or ethanol/Cremophor/saline systems). Any such use must be supported by institutionally approved protocols and is outside the scope of this product listing.

Item-specific pharmaceutical roles (dosage forms, compendial monographs, excipient functions): Not specified for this item; refer to CoA/Spec Sheet.

Users seeking clinical-grade material should source GMP-compliant alternatives and perform full CMC and quality assessments per regulatory requirements.

Physical Properties

Item-specific physicochemical data are not supplied in the product record.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point (MP): Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point (BP): Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index: Not applicable/Not specified for this item; refer to CoA/Spec Sheet.
  • pKa/logP: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Item-specific solubility not provided. For bioactive small molecules of this class, researchers commonly prepare concentrated stocks in anhydrous DMSO and dilute into assay buffer immediately before use (general practice; literature guidance).

Practical handling guidance (general, literature)

  • Many heteroaromatic kinase-tool molecules display limited aqueous solubility and improved stability in dry, oxygen-poor conditions. If precipitation is observed on dilution from DMSO into aqueous media, add DMSO in small aliquots or use co-solvents (e.g., PEG400 or ethanol at low final %), and warm gently to room temperature.
  • Always determine working concentration limits empirically and confirm clarity by visual inspection or nephelometry prior to biological assays.

Authoritative values, if required, should be taken from the batch CoA or specification sheet for this item.

Quality and Grades
  • Supplied grade: Moligand™. This denotes a small-molecule ligand quality suitable for biological research, screening, and probe applications. While not a clinical/compendial grade, Moligand™ emphasizes identity confirmation and purity appropriate for in vitro/in vivo research models.

What Moligand™ typically implies (general guidance)

  • Identity/purity: Lots are commonly supported by analytical characterization (e.g., LC–MS, NMR, HPLC purity) to enable reproducible biological experiments. Exact acceptance criteria and analytical methods are batch-specific; consult the CoA.
  • Stabilization/packaging: Products are often packaged under inert gas with desiccation to limit oxidative/hydrolytic degradation—the present item specifies argon charge and −20°C storage.
  • Low endotoxin and bioburden are not implied unless explicitly stated in the CoA/spec sheet.

Item-specific notes

  • Purity specification (percent, residual solvents, water, metals, UV cutoff): Not specified for this item; refer to CoA/Spec Sheet.
  • Stabilizers or counterions: Not specified for this item; refer to CoA/Spec Sheet.

Best practices for quality assurance

  • Verify lot-specific identity and purity upon receipt if your workflows demand stringent controls (e.g., quantitative biology). LC–MS retention time and exact mass comparison to CoA are practical checkpoints.
  • Maintain a chain of custody with storage logs and aliquot tracking to prevent quality drift through repeated freeze–thaw or moisture uptake.
Reaction and Applications

This product is offered as a life-science research ligand rather than as a synthetic reagent. Consequently, it is not typically employed as a stoichiometric reactant or solvent in classical organic reactions.

Research applications (general, literature/practice)

  • Small-molecule ligands of this class are commonly used as chemical probes in cell-based assays, target validation studies, and pathway interrogation. Typical workflows include dose–response viability assays, signaling phospho-readouts (e.g., immunoblotting), imaging of phenotypic outcomes, and temporal control experiments.
  • In model organisms, such ligands may be applied by immersion, microinjection, or feed for pathway modulation studies, subject to ethical and institutional guidelines.

Practical tips

  • Prepare fresh working solutions immediately prior to use. Include matched vehicle controls at the same final solvent concentration.
  • Confirm on-target biochemical effects by orthogonal readouts (e.g., target engagement assays, CETSA, or genetic knockdown/knockout comparisons) to mitigate off-target interpretation.
  • Verify compound integrity over the course of the experiment by analytical spot checks (e.g., LC–MS of remaining stock after multi-day studies).

If you intend to use this compound as a synthetic substrate or intermediate, consult the primary literature for structure-specific reactivity; item-specific reactivity data are not provided here.

Reaction Conditions

Not typically applicable. TCS 359 is supplied as a research ligand for biological assays rather than as a reagent for chemical synthesis.

If performing biological experiments (general guidance)

  • Stock solution preparation: Dissolve in anhydrous DMSO (e.g., 10–50 mM). Vortex and, if needed, sonicate briefly. Filter through 0.22 µm PTFE only if particulates persist and the compound is known to be filter-stable.
  • Working solutions: Dilute into pre-warmed assay medium with thorough mixing. Typical final DMSO ≤0.1–0.5% v/v (literature practice). Determine exposure time and dosing schedule empirically.
  • Stability checks: For multi-day studies, assess stock stability by LC–MS or HPLC.

Classical reaction parameters (solvent/temperature/catalyst/yield): Not applicable for this item based on current product data.

Safety and Handling

GHS classification and hazard statements for this specific item are not provided in the product data.

  • GHS/Signal word/H-statements/Pictograms: Not specified for this item; refer to SDS.
  • Intended use: For research use only (per product note). Not for human or veterinary use.

General safety guidance for small-molecule ligands (literature/practice)

  • PPE: Wear lab coat, safety glasses, and appropriate chemically resistant gloves. Handle powders and DMSO solutions in a fume hood to avoid inhalation or dermal exposure.
  • Incompatibilities: Avoid strong oxidizers and strong acids/bases unless part of a controlled procedure. Protect from moisture and air as the product is supplied argon-charged and recommended to be stored under inert atmosphere.
  • Hygroscopicity/air sensitivity: Store under inert gas; reseal promptly after opening. Minimize exposure to ambient humidity.
  • First aid (overview): In case of skin contact, wash with soap and water. If eye exposure occurs, rinse cautiously with water for several minutes and seek medical attention. If inhaled, move to fresh air; if swallowed, rinse mouth—do not induce vomiting; seek medical attention. Always follow institutional SOPs.
  • Spill response: Avoid dust formation; collect with inert absorbent, place in a sealed container for disposal according to local regulations.

Always consult the item-specific SDS for authoritative hazard classification and handling instructions.

Solvent Selection

TCS 359 is a research small molecule typically handled as concentrated stock solutions.

General solvent guidance (literature/practice)

  • Primary solvent: Anhydrous DMSO is the default for many kinase-pathway ligands due to broad solvency and assay compatibility at ≤0.1–0.5% v/v final DMSO.
  • Secondary options: DMF or ethanol can be used for initial dissolution if compatible with your assay; confirm no assay interference. For aqueous work, dilute DMSO stocks into buffered media (e.g., PBS, HEPES, culture media) with vigorous mixing to minimize precipitation.
  • Co-solvent strategies: If precipitation occurs upon aqueous dilution, increase final DMSO fraction incrementally (e.g., from 0.1% to 0.5–1%), or incorporate PEG400 or minimal ethanol as co-solvent, ensuring controls are matched.
  • Adsorption minimization: For low-concentration dosing, pre-wet plasticware with dilute DMSO or use low-bind tubes to reduce loss to surfaces.

Dielectric/polarity context

  • DMSO (ε ~47 at 20°C; polar aprotic) and DMF (ε ~36) support dissolution of polar, heteroatom-rich scaffolds; ethanol (ε ~24) provides greener handling but with reduced solvency. Values are literature references.

Comparison (general)

  • DMSO: maximal solvency, common in screening; potential biological effects above ~0.5–1%.
  • Ethanol: greener, volatile; allowable levels in some cell assays ≤0.2–0.5%.
  • Aqueous buffers: final working medium; avoid direct solid-to-buffer additions to prevent local supersaturation.
Storage and Reconstitution

Storage conditions (from product data)

  • Store at −20°C, argon charged.
  • Shipped in an ice chest with ice pads to maintain a cold chain.

Best practices

  • Keep tightly sealed under inert atmosphere with desiccant. Minimize exposure to air and moisture; allow vials to equilibrate to room temperature in a desiccator before opening to prevent condensation.
  • Aliquot upon first opening to single-use volumes to avoid repeated freeze–thaw cycles. Use low-bind tubes and cap under inert gas if possible.

Reconstitution (general guidance)

  • Solvent: Anhydrous DMSO is recommended for initial dissolution of many bioactive small molecules. Start with a small volume, vortex/sonicate gently, and adjust to the desired stock concentration (commonly 10–50 mM).
  • Working solutions: Dilute stocks into pre-warmed assay buffer or culture media with vigorous mixing to achieve the target concentration while keeping final DMSO low (e.g., ≤0.1–0.5% v/v), unless your system tolerates more.
  • Short-term stability: Keep thawed stocks on ice during use and return unused aliquots promptly to −20°C. Avoid repeated warming/cooling cycles.

Specifications such as exact solubility limits, stability in particular buffers, and freeze–thaw tolerance are not specified for this item; refer to the batch CoA/Spec Sheet.

Structure and Identity
  • Product name: TCS 359 (SKU: T129806); CAS: 301305-73-7; PubChem CID: 1048845
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • InChIKey: 91086 (as provided; appears truncated/not standard). For authoritative structure keys, refer to CoA/Spec Sheet.

Structural description

  • Item-specific structural features (functional groups, ring systems, stereochemistry): Not specified for this item; refer to CoA/Spec Sheet.
  • 2D structure in words: Detailed atom connectivity and functional motifs are not provided in the current product data. If your application requires an exact structural representation for docking, QSAR, or analytical confirmation, request the CoA/SDS where full identifiers are normally listed.

Notes

  • Category: Life science research small-molecule (Moligand grade).
  • Identity confirmation in practice: Users typically confirm via LC–MS/HRMS and 1H/13C NMR against supplier reference spectra; please refer to the batch-specific CoA for acceptance criteria.
Synthetic Utility

TCS 359 is offered as a biological research ligand rather than a building block or reagent. As such, it is not typically used for bond-forming reactions or as a synthetic intermediate.

  • Functional group reactivity and named-reaction participation are not described in the product data. If you intend to repurpose this molecule synthetically, consult structural literature corresponding to CAS 301305-73-7 and evaluate compatibility with your transformations.
  • For analytical or derivatization purposes, users sometimes prepare reference standards or labeled analogs; these activities require full structural information and should be guided by primary literature and validated analytical methods.

Item-specific synthetic guidance: Not specified for this item; refer to CoA/Spec Sheet.

Target Specificity

Item-specific biological target(s), binding constants, and selectivity against related proteins are not provided in the current product data.

  • Target(s): Not specified for this item; refer to CoA/Spec Sheet and primary literature for CAS 301305-73-7 / CID 1048845.
  • Species reactivity or pathway coverage: Not specified for this item.
  • Assay-validated activities: Not specified for this item.

Users should perform internal target-engagement validation (e.g., biochemical IC50, CETSA, pull-down, or phenotypic rescue) appropriate to their system.

Preguntas frecuentes

What is the purity of this product?
This product is supplied at ≥99% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
How should this product be stored?
Store at ?20 °C under argon. It is supplied under an argon blanket; reseal under inert gas after each use.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 301305-73-7, the molecular formula is C18H20N2O4S, and the molecular weight is 360.43 g/mol. InChIKey FSPQCTGGIANIJZ-UHFFFAOYSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

¿Necesita ayuda para elegir la calidad?

Nuestra guía de selección de calidades cubre la pureza, el estado del estabilizador y la idoneidad de la aplicación para todas las variantes de nuestro catálogo.

Ver la guía de calidades Moligand™ →

¿Quieres que te enviemos un mensaje cuando tengamos descuentos disponibles?

Recordármelo más tarde

¡Gracias! Por favor, revisa tu bandeja de entrada de correo electrónico para confirmar.

¡Vaya! Las notificaciones están desactivadas.